has been associated with the development of neurological dysfunction resembling Parkinson's disease (PD) 1 . Airborne Mn 2+ exposure in humans is a cause of neurotoxicity to the basal ganglia, resulting in a mixture of neuropsychiatric and motoric disturbances known as manganism 2 . Chronic Mn 2+ exposure is associated with a greater risk of developing PD amongst miners and welders, as well as populations living near ferroalloy industries 3 . In addition, the use of methylcyclopentadienyl manganese tricarbonyl (MMT) as a gasoline additive in some parts of the world could pose a danger to public health as MMT has been shown to be toxic to dopaminergic neurons 4 . With its extensive use in various industries, Mn 2+ exposure could be a silent pandemic affecting neuronal development, as well as the onset and course of neurodegeneration 5 . The proposed mechanism of Mn 2+ uptake into the brain involves the divalent metal transporter 1 (DMT1), a 12-transmembrane domain protein found in a range of tissues including duodenum, kidney and brain, and capable of transporting a number of divalent cations 6 . As both Mn 2+ and Fe 2+ rely heavily on DMT1 for cellular transport, prolonged exposure or chronic
supplementation could have potential applications in the prevention and treatment of Mn 2+ -mediated toxicity.
Although manganese (Mn 2+ ) is a trace metal element vital for biological functions, chronic exposure to Mn 2+ has been associated with the development of neurological dysfunction resembling Parkinson's disease (PD) 1 . Airborne Mn 2+ exposure in humans is a cause of neurotoxicity to the basal ganglia, resulting in a mixture of neuropsychiatric and motoric disturbances known as manganism 2 . Chronic Mn 2+ exposure is associated with a greater risk of developing PD amongst miners and welders, as well as populations living near ferroalloy industries 3 . In addition, the use of methylcyclopentadienyl manganese tricarbonyl (MMT) as a gasoline additive in some parts of the world could pose a danger to public health as MMT has been shown to be toxic to dopaminergic neurons 4 . With its extensive use in various industries, Mn 2+ exposure could be a silent pandemic affecting neuronal development, as well as the onset and course of neurodegeneration 5 . The proposed mechanism of Mn 2+ uptake into the brain involves the divalent metal transporter 1 (DMT1), a 12-transmembrane domain protein found in a range of tissues including duodenum, kidney and brain, and capable of transporting a number of divalent cations 6 . As both Mn 2+ and Fe 2+ rely heavily on DMT1 for cellular transport, prolonged exposure or chronic deficiency of either metal ion may interfere with the uptake and therefore the normal function of the other 7 . Indeed, Mn 2+ levels in humans and animals have been observed to be influenced by Fe 2+ status, specifically Mn 2+ loading during Fe 2+ deficiency [7] [8] [9] [10] [11] . While epidemiological and animal studies have demonstrated the detrimental effects of Mn 2+ exposure, the cell signaling pathways involved in Mn 2+ toxicity and its interaction with Fe 2+ are still not well understood. In our current study, we demonstrate that Mn 2+ mediates cytotoxicity via depletion of cytoplasmic Fe 2+ and activation of the JNK pathway. Importantly, we show that Fe 2+ -repletion suppressed Mn 2+ -mediated JNK activation, suggesting that Fe 2+ supplementation can modify Mn 2+ -mediated cytotoxicity. Furthermore, our findings implicate the importance of the autophagic-lysosomal pathway in the degradation of ferritin since lysosomal inhibition further exacerbated cellular stress. Finally, we reduced JNK activation by overexpressing thioredoxin protein or inhibiting ASK1, suggesting the involvement of ASK1 upstream of the JNK pathway in Mn 2+ toxicity. Taken together, our results provide evidence that Mn 2+ cytotoxicity is related to Fe 2+ depletion and the activation of JNK signaling via the thioredoxin/ASK1 pathway mediates cell death. These findings have important implications for the use of Fe 2+ supplementation to reduce Mn 2+ loading and toxicity in high risk populations.
Results

DMT1 overexpression in neuronal SH-SY5Y cells.
To test the hypothesis that DMT1 mediates Mn 2+ cytotoxicity, we used a previously generated geneticin-resistant stable SH-SY5Y cell line overexpressing DMT1 (S-DMT1) 12 to transport Mn 2+ into the cell. The expression of the DMT1-GFP fusion protein was verified using western blot analysis and fluorescence microscopy. DMT1-GFP protein is highly expressed in the S-DMT1 cells, as detected using DMT1B monoclonal antibody (Fig. 1A) . The vector cell line overexpressing GFP protein (SGFP) showed the expression of the endogenous DMT1 at approximately 66 kDa while S-DMT1 cells showed further DMT1 immunoreactivity at 90 kDa and 250 kDa. The 90 kDa and 250 kDa bands correspond to DMT1-GFP and glycosylated DMT1-GFP fusion proteins 13 respectively. Additionally, the DMT1-GFP protein was also viewed directly using fluorescence imaging to validate the cellular distribution of GFP compared to DMT1-GFP (Fig. 1B) . In the S-DMT1 cells, DMT1-GFP was observed as puncta and located at the periphery of the cell, while SGFP cells showed diffuse cytoplasmic GFP expression. Indeed, studies of DMT1 transfected into non-neuronal cells such as Hep2 and CHO cells also confirm its plasma membrane and lysosomal localization 14, 15 . Together, our data demonstrates that the localization of DMT1 overexpressed in SH-SY5Y cells is consistent with that of endogenous DMT1 in primary neuronal cells 16 .
DMT1-mediated Mn
2+ uptake, cytoplasmic accumulation and reduction in cell viability. Previously by measuring the amount of calcein fluorescence that is being quenched by the metal ions 17 . When S-DMT1 cells were treated with Mn 2+ for 30 min, there was a concentration-dependent quenching of calcein fluorescence ( Fig. 2A) . In contrast, while Fe 2+ treatment mediated a reduction in calcein fluorescence, the reduction itself was not concentration-dependent (Fig. 2B ). This indicates that DMT1 mediates robust entry and accumulation of labile Mn 2+ . In parallel with this accumulation, S-DMT1 cells treated with Mn 2+ for 24 h displayed significant reduction in cell viability compared to vector SGFP cells (Fig. 2C) . Unlike Mn 2+ however, increasing concentrations of Fe 2+ were not associated with the progressive accumulation of its labile form. Moreover, in contrast to Mn 2+ , Fe 2+ treatment did not result in any significant reduction in S-DMT1 cell viability compared to SGFP cells (Fig. 2D) . This suggests that cells may have a protective mechanism against the build-up of labile iron. A likely candidate in this case would be the ferritin heavy chain (FTH1), which converts Fe 2+ into the non-labile Fe 3+ form. Indeed, we found that the level of ferritin was dramatically upregulated in cells treated with Fe 2+ for 12 h and this occurred in a concentration-dependent fashion (Fig. 2E) .
Cell viability reduction mediated by Mn
2+ is associated with the activation of MAP Kinase JNK pathway. Given that the MAP kinase stress-induced pathway plays an important role in the regulation of cell proliferation, differentiation, survival and apoptosis 18 , we next sought to examine the potential effect of Mn 2+ on this pathway. At 1 mM Mn 2+ , S-DMT1 cells showed a dramatic increase in JNK phosphorylation in a time-dependent fashion compared to SGFP cells (Fig. 3A , blots were developed with the same exposure time). Treatment with 1 mM Fe 2+ did not significantly increase JNK phosphorylation in both SGFP and S-DMT1 cells. Since Mn 2+ treatment of S-DMT1 cells resulted in enhanced JNK phosphorylation, we next questioned whether JNK phosphorylation was responsible for Mn 2+ -mediated reduction in cell viability. To examine this, we used 25 μ M of SP600125, an inhibitor of JNK phosphorylation. S-DMT1 cells treated with 0.5 or 1 mM Mn 2+ for 12 h showed increased JNK phosphorylation compared to untreated cells. This phosphorylation was significantly suppressed with addition of SP600125 (Fig. 3B) . Notably, the more than 2-fold increase in JNK phosphorylation mediated by 1 mM Mn 2+ treatment was totally abolished in the presence of SP600125. Under phase contrast microscopy, S-DMT1 cells treated with SP600125 showed reduced vulnerability to Mn 2+ compared to cells treated with Mn 2+ alone. Indeed, using the MTT cell viability assay, S-DMT1 cells treated with a range of Mn 2+ concentrations for 24 h were significantly protected against Mn 2+ cytotoxicity in the presence of SP600125 (Fig. 3C ). The data suggests that JNK activation plays an important role in Mn
2+
-mediated cell death.
Autophagic activity associated with Mn
2+ treatment is protective during Mn 2+ stress. In our previous work, we showed that chronic Fe 2+ overload together with α -synuclein A53T overexpression led to an increase in autophagic activity and cell death 12 . We thus investigated whether autophagy could be involved in Mn 2+ -mediated cytotoxicity. Upon autophagy induction, cytoplasmic LC3-I is lipidated to LC3-II, which then localizes to autophagic vesicles 19 . To determine the level of autophagic activity in Mn 2+ -treated cells, naïve SH-SY5Y cells were transfected with the mRFP-GFP tandem fluorescence-tagged LC3 construct (tf-LC3) for 24 h. Transfected cells treated with 0.5 mM Mn 2+ for 6 h showed induction of autophagy as indicated by the increase in average red LC3 puncta per cell compared to untreated cells (Fig. 4A ). The green GFP puncta associated with tf-LC3 was lost in Mn 2+ -treated cells presumably due to the quenching of the GFP signal within the acidic lysosomes. To reverse the loss of GFP puncta signal, cells were co-treated with Mn 2+ and NH 4 Cl (which neutralizes the pH of lysosomes) and the GFP signal reappeared and colocalized with the red LC3 puncta in the merged image. Cells treated with either 0.5 mM Fe 2+ or 0.5 mM Fe 2+ + Mn 2+ for 6 h did not show any significant increase in the number of LC3 puncta, suggesting that autophagy was not significantly changed with these treatments. Cells treated with EBSS for 6 h (which promotes starvation-induced autophagy) was used as a positive control for autophagy induction. In addition, we used western blot analysis to detect the level of LC3-II, which acts as a marker for autophagy. S-DMT1 cells treated with 0.5 mM Mn 2+ for 12 h showed a substantial accumulation of LC3-II compared to untreated cells (Supplementary Fig. 2A ), while 0.5 mM Fe 2+ and 0.5 mM Fe 2+ + Mn 2+ treatments did not result in any significant change. The data suggests that Mn 2+ mediates robust autophagy activation in S-DMT1 cells, while this was not observed with Fe . Importantly, by simply co-treating with Fe 2+ , the activation of autophagy induced by Mn 2+ could be reversed. With the robust activation of autophagy upon Mn 2+ stress, we examined the effect of autophagy on cell viability by using ATG5 autophagy-deficient mouse embryonic fibroblast cells (ATG5 −/− MEF). ATG5 is an important gene required for the initiation of autophagy 20, 21 . Treatment of ATG5 +/+ and ATG5 −/− MEF with NH 4 Cl for 12 h neutralized lysosome pH, preventing autophagic degradation and allowing the accumulation of LC3-II protein in the ATG5 +/+ MEF but not in ATG5 −/− (Fig. 4B) . This verifies the failure of ATG5 −/− MEF to initiate autophagy. We then carried out the MTT cell viability assay and found that ATG5 −/− MEF treated with 2 mM Mn 2+ showed significant reduction in cell viability compared to ATG5 +/+ MEF. Under phase contrast microscopy, autophagy deficient ATG5 −/− MEF also showed increased vulnerability to Mn 2+ cytotoxicity (Fig. 4C) . As lysosomal acidification is important for proteolysis of ferritin to extract labile Fe 2+ 22 , the inhibition of lysosomal function by NH 4 Cl could potentially aggravate Mn 2+ -mediated cytotoxicity. To test this, we treated S-DMT1 cells with NH 4 Cl and found that Mn 2+ -mediated JNK phosphorylation was indeed significantly higher from 2 h onwards compared to Mn 2+ alone ( Supplementary Fig. 2B ). In addition the inhibition of lysosomal function could be seen from the accumulation of autophagic LC3-II, which would otherwise be degraded by the lysosomes. (Fig. 5B) . However, the addition of autophagy inhibitor NH 4 Cl almost completely prevented Mn 2+ -mediated degradation of ferritin. Since lysosomal acidification is essential for the degradation of ferritin in order to release Fe 2+ 23 , we validated the importance of the basal autophagy-lysosomal pathway for the maintenance of Fe 2+ homeostasis.
Mn
Immunoblotting of ATG5
−/− MEF treated with increasing concentrations of Fe 2+ for 12 h showed dramatic upregulation and accumulation of ferritin protein compared to ATG5 +/+ MEF (Fig. 5C ). In addition, mitochondrial SOD2 was observed to be relatively higher (independent of Fe 2+ treatment) in the ATG5 −/− compared to Fig. 3B ). Additionally, the cells appeared healthier as observed using phase contrast microscopy.
We next examined the response of S-DMT1 cells to the reverse experiment by inducing Fe 2+ deficiency with the cell permeable Fe 2+ chelator 1,10-phenanthroline. In contrast to Fe 2+ repletion, Fe 2+ depletion resulted in significant toxicity. Treatment with 75 μ M phenanthroline (Phen) alone for 12 h led to JNK phosphorylation, which could be reversed by supplementation with 0.5 mM Fe 2+ (Fig. 5D ). (Fig. 6A) . We then investigated whether thioredoxin overexpression could rescue cells from Mn 2+ cytotoxicity. Mn 2+ treatment of S-DMT1 cells transfected with thioredoxin for 24 h showed a significant increase in cell viability compared to Mn 2+ treatment alone (Fig. 6B) . Thioredoxin overexpression also increased cell viability for Mn 2+ and NH 4 Cl treatment. Finally, we used NQDI-1, an ASK1 inhibitor 25 , to investigate the involvement of ASK1 and the downstream components MKK4 and JNK 26 . On treatment with Mn 2+ , MKK4 and JNK showed robust activation and this was reduced when NQDI-1 was added to inhibit ASK1 activity (Fig. 6C) . Co-treatment of Mn 2+ with Fe 2+ also reduced MKK4 and JNK activation, presumably because Fe 2+ supplementation reduced ASK1-thioredoxin dissociation and subsequent ASK1 activation. Taken together, this suggests that Mn 2+ exposure results in cellular Fe 2+ disruption with a concomitant increase in JNK phosphorylation via the thioredoxin/ASK1/MKK4 pathway (Fig. 7) .
Discussion
Nutritional iron deficiency affects a significant proportion of the world population. In 2011, it was estimated that around 800 million women and children suffer from anemia, of which 50% is attributed to iron-deficiency 27 . An important consequence of iron deficiency is an apparent heightened risk of heavy-metal poisoning, especially in children, which may affect their neurodevelopment. Iron-deficient individuals have an increased absorption capacity that is not specific to iron, resulting in increased absorption of other divalent heavy metals such as manganese, lead and cadmium 28 . Prevention of iron deficiency could thus reduce the number of children susceptible to heavy-metal poisoning from contaminated water, lead paint and pollution from automobile, industrial or welding fumes 27 . Since the DMT1 transporter has been shown to mediate the uptake of both Mn 2+ and Fe 2+ in the brain 29 , we generated SH-SY5Y stable cell lines overexpressing DMT1 to better understand the signaling pathways involved in the interaction of these two ions. DMT1 facilitated a concentration-dependent uptake of Mn 2+ into the cytoplasm. This cytoplasmic accumulation of labile Mn 2+ contributed substantially to cell toxicity since there is no known storage protein for Mn 2+ . In contrast, cells treated with Fe 2+ only showed a 25% increase in labile Fe 2+ , which did not significantly affect cell viability. This is due to the presence and upregulation of ferritin protein upon Fe 2+ exposure. Ferritin is a Fe 3+ -storage protein with ferroxidase activity that protects cells against Fe 2+ -mediated cytotoxicity 30 . Although Mn 2+ and Fe 2+ share similar physical and chemical properties, the cellular requirement for each metal ion is highly specific in order for them to catalyze reactions in their respective metabolic pathways.
shows (Fig. 7) . We also found that autophagy was essential for the degradation of iron-laden ferritin in order to maintain the necessary level of cellular Fe 2+ during Mn 2+ exposure. This was corroborated through the inhibition of lysosome function which prevented the degradation of ferritin and hence failure of Fe 2+ release. Indeed, the role of autophagy in maintaining cellular Fe 2+ balance is supported by the recent identification of the nuclear receptor coactivator 4 (NCOA4), which is responsible for the selective targeting of ferritin to the lysosomes for protein turnover 31 . NCOA4 co-localizes with ferritin and LC3B in autophagosomes upon upregulation of ferritin by ferric ammonium citrate. In addition, either ATG5 or NCOA4 knockdown through RNA interference retarded ferritin turnover. This provided a molecular explanation on how the bioavailability of Fe 2+ is maintained within the cell through autophagy, a process which the authors referred to as 'ferritinophagy' .
In 
Methods
Generation of DMT1-GFP and Vector Stable Cell Lines. cDNA of DMT1 (Accession: AF153279) without the iron-response element (IRE) at the 3′ UTR was subcloned into a GFP vector to generate DMT1-GFP. The generation and characterization of the DMT1 stable cell lines were performed by our laboratory and described previously 12 . The DMT1 stable cell line (S-DMT1) and empty vector control (SGFP) were maintained in 200 μ g/ml G418 (Gibco) supplemented DMEM containing 10% FBS and 1% Pen/Strep in 5% CO 2 at 37 °C. The TRX1-Flag plasmid was obtained from Addgene (plasmid: 21283) and was previously described 32 .
ATG5
− Cell transfection and treatment. Cell transfection was performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Cells of at least 70% confluency were transfected with the desired plasmid constructs for 24 h before being subjected to various treatments.
Overexpression of LC3.
The mRFP-GFP tandem fluorescent-tagged LC3 (tf-LC3) construct was previously described in our work 12 . Briefly, mRFP retained its red fluorescence in acidic lysosomes, but GFP fluorescence was quenched and could be recovered by neutralizing lysosome pH with NH 4 Cl. Transfection of tf-LC3 into SH-SY5Y cells was performed using Lipofectamine 2000 (Invitrogen). After 24 h, the cells were treated with various metal ions and chemical inhibitors for 6 h before fixing with 2.5% PFA and viewing with a confocal microscope (Olympus).
Calcein-AM Metal Quenching Assay. Calcein acetoxymethylester (Calcein-AM, 0.25 μ M) was dissolved in DMSO. Briefly, cells were treated with metal ions for 30 min, then rinsed with PBS and incubated with calcein-AM in DMEM for 20 min at 37 °C, 5% CO 2. The cells were rinsed in PBS followed by complete lysis in RIPA buffer containing 150 mM NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS and 50 mM Tris, pH 8. The supernatant was transferred to a 96-well plate for fluorescence analysis at 488/518 nm wavelength (Tecan Infinite 200 PRO multimode reader). The fluorescence of the lysates was normalized to protein concentration determined using BCA method (Thermo Scientific).
Cell viability assay. Cell viability was determined using the MTT Cell Proliferation Kit (Roche) according to the manufacturer's protocol. Cells were seeded into a 96-well plate to reach a confluency of 70%. The cells were then treated with Mn 2+ , Fe 2+ or other chemicals for 24 h before analysis using MTT.
Protein Lysis and Western Blot Analysis. Protein extraction was carried out by lysing cells in PBS buffer containing 1% Triton X-100 with added protease and phosphatase inhibitors (Roche). Protein content was determined using Bradford assay (Pierce). Approximately 25 to 70 μ g of total protein was resolved on 8, 10 or 12% SDS-PAGE gel before transferring onto PVDF membrane (Millipore) for detection using ECL reagent (Pierce).
The following antibodies were used: anti-phospho-JNK, anti-JNK, anti-phospho-MKK4, anti-MKK4, anti-FTH1 (Cell Signaling Technology), anti-TRX (Santa Cruz), anti-LC3B (Abgent), anti-SOD2 (Abcam), anti-actin and HRP-conjugated anti-rabbit and anti-mouse (Sigma).
